OpTmizer™ CTS™ T-Cell Expansion Supplement
GUDID 10190302005173
LIFE TECHNOLOGIES CORPORATION
Ex vivo cell culture medium| Primary Device ID | 10190302005173 |
| NIH Device Record Key | f1fc2f38-2985-4044-9037-d57417b02d0b |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | OpTmizer™ CTS™ T-Cell Expansion Supplement |
| Version Model Number | A1048402 |
| Company DUNS | 118793157 |
| Company Name | LIFE TECHNOLOGIES CORPORATION |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
Device Identifiers
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 10190302005173 [Primary] |
FDA Pre-market Approvals/Notifications & deNovo
- Premarket Notification: K113566
FDA Product Code
| NDS | MEDIA, CULTURE, EX VIVO, TISSUE AND CELL |
Sterilization
| Steralize Prior To Use | false |
| Device Is Sterile | true |
Device Entry Metadata
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 5 |
| Public Version Date | 2019-04-24 |
| Device Publish Date | 2016-08-01 |
Devices Manufactured by LIFE TECHNOLOGIES CORPORATION
| 10190302005197 - Aim -V™ Medium | 2024-06-04 AIM V MED |
| 10190302012041 - Human CD99 FITC Conjugate | 2024-06-04 HU CD99 3B2/TA8 FITC MAB |
| 10190302012058 - Human CD99 R-PE Conjugate | 2024-06-04 HU CD99 3B2/TA8 PE MAB |
| 10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04 HU CXCR4 12G5 PE MAB |
| 10190302012164 - Anti-Human HLA-DR (Class II) FITC Conjugate | 2024-06-04 HU HLA-DR TU36 FITC MAB |
| 10190302012171 - Anti-Human HLA-DR (Class II) R-PE Conjugate | 2024-06-04 HU HLA-DR TU36 PE MAB |
| 10190302012188 - Anti-Human HLA-DR (Class II) APC Conjugate | 2024-06-04 HU HLA-DR TU36 APC MAB |
| 10190302012195 - Anti-Human HLA-DR (Class II) PE-Texas Red® Conjugate | 2024-06-04 HU HLA-DR TU36 PE-TX RED MAB |
Trademark Results [OpTmizer]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OPTMIZER 98689540 not registered Live/Pending |
Life Technologies Corporation 2024-08-08 |
 OPTMIZER 97529880 not registered Live/Pending |
Wuwei Qingmeng Electronic Commerce Co.,Ltd. 2022-08-01 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.